Details
Description
The 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held August 26-30, 2017, in Montreal, Canada. More information on the conference can be found here.
A variety of Sentinel-related work was featured, including a plenary session, presentations, posters, and more. These materials have been made available below.
Event Materials
Plenary
Podium/Oral Presentations
- Tumor Necrosis Factor-α Inhibitor (TNFi) Utilization Among Women with Live Birth Pregnancies
- Impact of ICD-10-CM Transition on Selected Cardiovascular-Related Events in the Sentinel System
- Identification of Name Confusion Medication Errors in the US FDA's Sentinel System
- Feasibility Analysis of Mortality Outcomes in the Sentinel Distributed Database
- Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA's Sentinel System
- Curating Inpatient Medication Use Data from a Hospital Network Electronic Medication Administration Record (eMAR) System: Lessons from the Sentinel System About Expanding Drug Safety Surveillance Potential
- Prospective Surveillance Pilot of Rivaroxaban Safety within the US Food and Drug Administration Sentinel System
- Randomized Clinical Trial Using FDA's Sentinel Infrastructure: An Analysis Assessing Feasibility
- Developing a Mother-Infant Cohort in Sentinel's PRISM Program as a Resource to Monitor the Safety of Vaccine Use During Pregnancy
- Protocol-Based Assessment of Thromboembolic Events (TEEs) after Intravenous Immune Globulin (IVIg) in the Sentinel Distributed Database (2006-2012)
- Practical Lessons Learned for Identification of Thromboembolic Events and Intravenous Immunoglobulin Exposure in the Sentinel Distributed Database
- Developing a Mobile App for Studies of Medication Safety
- Expansion of the US FDA's Sentinel System to Inpatient Blood Transfusion Data from Hospital Corporation of America: New Surveillance Options
Posters
- Distributed Regression Analysis in a Distributed Health Data Network
- Dispensings of Influenza Antiviral Medications in the Sentinel System as a Source of Data for Influenza Surveillance
- Evaluation of Test Data in Distributed Research Networks: A Sentinel System Example
- Early Post-Approval Surveillance of New Molecular Entity Uptake in the Sentinel Distributed Database
- A Review of Methods for Propensity Score Matched Subgroup Analysis and Their Application in Peer Reviewed Research Studies
- Type 1 and Type 2 Diabetes Mellitus Identification Using ICD-9-CM Codes Within a Cohort of New Users of Drugs Labeled for Type 2 Diabetes Mellitus
- Trends of Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccination During Pregnancy in the Sentinel System
- Evaluation of Case-Finding Algorithm for Venous Thromboembolism Outcome
- Opportunities for Rapid Monitoring of New Cancer Treatments: Tyrosine Kinase Inhibitors in the Sentinel Distributed Database
- Assessment of Transfusion-Related Acute Lung Injury After Red Blood Cell, Plasma and Platelet Administration: Initial Results in the Sentinel System
Symposia
- Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year
- Listening to Patient Voices in Pharmacoepidemiological Research - Opportunities for Innovation and Inclusion
- Promises and Challenges of Screening for Adverse Events in Sentinel
Workshop
Pre-Conference Course